BBLG Q1 2017 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q1 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$2M

Net Income

-$3M

EPS (Diluted)

$-480.00

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$507,768

Balance Sheet

Total Assets

$2M

Total Liabilities

$10M

Stockholders' Equity

-$8M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$2M	-$7M	+67.1%
Net Income	-$3M	-$7M	+55.9%